In this video, Owain Bennallack looks back at the saga caused by Pfizer‘s initial interest in AstraZeneca (LSE: AZN) (NYSE: AZN.US), and the UK-listed Big Pharma company’s rebuttal of its takeover offers.
https://youtu.be/yZELt0W0RK4
VIDEO: One Fool puts the spotlight on AstraZeneca plc (LON:AZN).
The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.
In this video, Owain Bennallack looks back at the saga caused by Pfizer‘s initial interest in AstraZeneca (LSE: AZN) (NYSE: AZN.US), and the UK-listed Big Pharma company’s rebuttal of its takeover offers.
https://youtu.be/yZELt0W0RK4